Multiple viral, bacterial, and host proteins

The designation "Multiple viral, bacterial, and host proteins" refers generically to a wide array of proteins derived from viruses, bacteria, and host (human or animal) organisms. This term represents a collective group of unrelated molecular entities with vastly different structures, functions, and biological significance, rather than a specific molecule or therapeutic target. In current biomedical and drug discovery practice, valid target entries should refer to a singular, well-defined molecular entity—such as a specific protein, receptor, enzyme, or gene—rather than a broad class or an unspecified group. Therefore, this entry is too generic, inherently ambiguous, and not scientifically actionable for downstream purposes such as drug targeting or biomarker development[2][3][7]. **Key reasons this is not a valid target:** - It aggregates distinct molecules representing completely different families and classes (e.g., viral proteases, bacterial toxins, host immune regulators)[2][7]. - Each subgroup (viral, bacterial, host) includes thousands of unique proteins with unrelated biological functions, disease roles, and druggability profiles[5][1]. - No canonical abbreviation, aliases, molecular classification, or disease role can be attributed to such a collective entity. **If interested in drug targets within these categories:** - *Viral proteins* might refer to specific enzymes (e.g., HIV protease), receptors, or structural proteins. - *Bacterial proteins* could indicate toxins, enzymes (e.g., beta-lactamase), or surface antigens. - *Host proteins* often refers to cellular factors exploited by pathogens (e.g., CCR5 in HIV entry, or immune response proteins such as CRP and TRAIL for diagnostics)[2][6]. It is recommended to specify a single, discrete protein (by gene/protein name or accession) from the viral, bacterial, or host proteome for all structured and scientific applications.